1 Ocak 2020 Dergi makalesi Açık Erişim

Turgut, Kursad; Sen, Ismail; Ince, Mehmet Ege; Naseri, Amir; Suleymanoglu, Havva; Ertan, Merve; Sagmanligil, Vedat

DataCite XML

<?xml version='1.0' encoding='utf-8'?>
<resource xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://datacite.org/schema/kernel-4" xsi:schemaLocation="http://datacite.org/schema/kernel-4 http://schema.datacite.org/meta/kernel-4.1/metadata.xsd">
  <identifier identifierType="URL">https://aperta.ulakbim.gov.tr/record/4409</identifier>
  <creators>
    <creator>
      <creatorName>Turgut, Kursad</creatorName>
      <givenName>Kursad</givenName>
      <familyName>Turgut</familyName>
      <affiliation>Near East Univ, Fac Vet Med, Dept Internal Med, F-99280 Nicosia, North Cyprus, France</affiliation>
    </creator>
    <creator>
      <creatorName>Sen, Ismail</creatorName>
      <givenName>Ismail</givenName>
      <familyName>Sen</familyName>
      <affiliation>Kyrgyz Turkish Manas Univ, Fac Vet Med, Dept Internal Med, Bishkek 720011, Kyrgyzstan</affiliation>
    </creator>
    <creator>
      <creatorName>Ince, Mehmet Ege</creatorName>
      <givenName>Mehmet Ege</givenName>
      <familyName>Ince</familyName>
      <affiliation>Near East Univ, Fac Vet Med, Dept Internal Med, F-99280 Nicosia, North Cyprus, France</affiliation>
    </creator>
    <creator>
      <creatorName>Naseri, Amir</creatorName>
      <givenName>Amir</givenName>
      <familyName>Naseri</familyName>
      <affiliation>Selcuk Univ, Fac Vet Med, Dept Internal Med, TR-42003 Konya, Turkey</affiliation>
    </creator>
    <creator>
      <creatorName>Suleymanoglu, Havva</creatorName>
      <givenName>Havva</givenName>
      <familyName>Suleymanoglu</familyName>
      <affiliation>Near East Univ, Fac Vet Med, Dept Internal Med, F-99280 Nicosia, North Cyprus, France</affiliation>
    </creator>
    <creator>
      <creatorName>Ertan, Merve</creatorName>
      <givenName>Merve</givenName>
      <familyName>Ertan</familyName>
      <affiliation>Near East Univ, Fac Vet Med, Dept Internal Med, F-99280 Nicosia, North Cyprus, France</affiliation>
    </creator>
    <creator>
      <creatorName>Sagmanligil, Vedat</creatorName>
      <givenName>Vedat</givenName>
      <familyName>Sagmanligil</familyName>
      <affiliation>Near East Univ, Fac Vet Med, Dept Physiol, F-99280 Nicosia, North Cyprus, France</affiliation>
    </creator>
  </creators>
  <titles>
    <title>The End-Systolic Wall Stress/End-Systolic Volume Index Ratio For Systolic Function In Anatolian Shepherd Dogs With Stage B2 Degenerative Mitral Valve Disease</title>
  </titles>
  <publisher>Aperta</publisher>
  <publicationYear>2020</publicationYear>
  <dates>
    <date dateType="Issued">2020-01-01</date>
  </dates>
  <resourceType resourceTypeGeneral="Text">Journal article</resourceType>
  <alternateIdentifiers>
    <alternateIdentifier alternateIdentifierType="url">https://aperta.ulakbim.gov.tr/record/4409</alternateIdentifier>
  </alternateIdentifiers>
  <relatedIdentifiers>
    <relatedIdentifier relatedIdentifierType="DOI" relationType="IsIdenticalTo">10.9775/kvfd.2019.22661</relatedIdentifier>
  </relatedIdentifiers>
  <rightsList>
    <rights rightsURI="http://www.opendefinition.org/licenses/cc-by">Creative Commons Attribution</rights>
    <rights rightsURI="info:eu-repo/semantics/openAccess">Open Access</rights>
  </rightsList>
  <descriptions>
    <description descriptionType="Abstract">This study was performed to evaluate the end systolic wall stress/end-systolic volume index ratio (ESWS/ESV-I) for LV systolic function in Anatolian shepherd dogs (ASHs) with stage B2 degenerative mitral valve disease (DMVD). Thirty-eight adult ASHs with DMVD (experimental group; 20 B1 dogs and 18 B2 dogs) and 30 weight-matched adult healthy ASHs (control group) were used as subjects. There was no overlap for the ESW5/ESV-I ratio (0.83 +/- 0.03, range: 0.61-1.09 for B2 dogs, 1.34 +/- 0.05, range: 1.11-1.89 for B1 dogs, 2.171 +/- 0.0 range: 1.91-3.02 for the control dogs) among the groups. ESWS/ESV-I ratio (&amp;lt;= 1.09) in ASHs with stage B2 DMVD may play a developmental role in left ventricular remodelling and risk factor for development of systolic dysfunction.</description>
  </descriptions>
</resource>